Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,296.34
(
0.13%
)
News Focus
News Focus
Post# of 1330
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$Pistol Pete$

Send PM Follow Ignore
Followers 2528
Posts 250766
Boards Moderated 33
Alias Born 05/06/2014

$Pistol Pete$

Re: creakyhottie post# 1058

Thursday, 08/27/2020 4:31:51 PM

Thursday, August 27, 2020 4:31:51 PM

Post# of 1330
$TRVN Trevana announced two publications of the respiratory safety data from the OLINVYK development program
7:04 AM ET 8/26/20 | Briefing.com
Related Quotes


4:00 PM ET 8/27/20
Symbol Last % Chg
TRVN
1.57 2.61%
Real time quote.

Study Summary and Key Findings:

OLINVYK was associated with a higher probability of analgesia than respiratory depression, while the reverse was true for morphine.
The clinical utility function model predicted there would be a lower probability of a respiratory event occurring with OLINVYK versus morphine.

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent TRVN News
More TRVN News